Literature DB >> 35499627

Endothelial Prohibitin Mediates Bidirectional Long-Chain Fatty Acid Transport in White and Brown Adipose Tissues.

Zhanguo Gao, Alexes C Daquinag, Yongmei Yu, Mikhail G Kolonin.   

Abstract

The function of prohibitin-1 (PHB1) in adipocyte mitochondrial respiration, adaptive thermogenesis, and long-chain fatty acid (LCFA) metabolism has been reported. While intracellular PHB1 expression is ubiquitous, cell surface PHB1 localization is selective for adipocytes and endothelial cells of adipose tissue. The importance of PHB1 in adipose endothelium has not been investigated, and its vascular cell surface function has remained unclear. Here, we generated and analyzed mice with PHB1 knock-out specifically in endothelial cells (PHB1 EC-KO). Despite the lack of endothelial PHB1, mice developed normally and had normal vascularization in both white adipose tissue and brown adipose tissue (BAT). Tumor and ex vivo explant angiogenesis assays also have not detected a functional defect in PHB1 KO endothelium. No metabolic phenotype was observed in PHB1 EC-KO mice raised on a regular diet. We show that both male and female PHB1 EC-KO mice have normal body composition and adaptive thermogenesis. However, PHB1 EC-KO mice displayed higher insulin sensitivity and increased glucose clearance when fed a high-fat diet. We demonstrate that the efficacy of LCFA deposition by adipocytes is decreased by PHB1 EC-KO, in particular in BAT. Consistent with that, EC-KO mice have a defect in clearing triglycerides from systemic circulation. Free fatty acid release upon lipolysis induction was also found to be reduced in PHB1 EC-KO mice. Our results demonstrate that PHB1 in endothelial cells regulates bidirectional LCFA transport and thereby suppresses glucose utilization.
© 2022 by the American Diabetes Association.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35499627      PMCID: PMC9233243          DOI: 10.2337/db21-0972

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.337


  21 in total

1.  Liver-specific deletion of prohibitin 1 results in spontaneous liver injury, fibrosis, and hepatocellular carcinoma in mice.

Authors:  Kwang Suk Ko; Maria Lauda Tomasi; Ainhoa Iglesias-Ara; Barbara A French; Samuel W French; Komal Ramani; Juan José Lozano; Pilsoo Oh; Lina He; Bangyan L Stiles; Tony W H Li; Heping Yang; M Luz Martínez-Chantar; José M Mato; Shelly C Lu
Journal:  Hepatology       Date:  2010-10-01       Impact factor: 17.425

Review 2.  Prohibitin ligands: a growing armamentarium to tackle cancers, osteoporosis, inflammatory, cardiac and neurological diseases.

Authors:  Dong Wang; Redouane Tabti; Sabria Elderwish; Hussein Abou-Hamdan; Amel Djehal; Peng Yu; Hajime Yurugi; Krishnaraj Rajalingam; Canan G Nebigil; Laurent Désaubry
Journal:  Cell Mol Life Sci       Date:  2020-02-15       Impact factor: 9.261

Review 3.  Fibrosis and adipose tissue dysfunction.

Authors:  Kai Sun; Joan Tordjman; Karine Clément; Philipp E Scherer
Journal:  Cell Metab       Date:  2013-08-15       Impact factor: 27.287

4.  Adipocyte-specific inactivation of Acyl-CoA synthetase fatty acid transport protein 4 (Fatp4) in mice causes adipose hypertrophy and alterations in metabolism of complex lipids under high fat diet.

Authors:  Lena-Solveig Lenz; Jana Marx; Walee Chamulitrat; Iris Kaiser; Hermann-Josef Gröne; Gerhard Liebisch; Gerd Schmitz; Christoph Elsing; Beate K Straub; Joachim Füllekrug; Wolfgang Stremmel; Thomas Herrmann
Journal:  J Biol Chem       Date:  2011-07-31       Impact factor: 5.157

5.  Vascular ligand-receptor mapping by direct combinatorial selection in cancer patients.

Authors:  Fernanda I Staquicini; Marina Cardó-Vila; Mikhail G Kolonin; Martin Trepel; Julianna K Edwards; Diana N Nunes; Anna Sergeeva; Eleni Efstathiou; Jessica Sun; Nalvo F Almeida; Shi-Ming Tu; Gregory H Botz; Michael J Wallace; David J O'Connell; Stan Krajewski; Jeffrey E Gershenwald; Jeffrey J Molldrem; Anne L Flamm; Erkki Koivunen; Rebecca D Pentz; Emmanuel Dias-Neto; João C Setubal; Dolores J Cahill; Patricia Troncoso; Kim-Ahn Do; Christopher J Logothetis; Richard L Sidman; Renata Pasqualini; Wadih Arap
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-02       Impact factor: 11.205

6.  Prohibitin/annexin 2 interaction regulates fatty acid transport in adipose tissue.

Authors:  Ahmad Salameh; Alexes C Daquinag; Daniela I Staquicini; Zhiqiang An; Katherine A Hajjar; Renata Pasqualini; Wadih Arap; Mikhail G Kolonin
Journal:  JCI Insight       Date:  2016-07-07

Review 7.  Brown and Beige Fat: Physiological Roles beyond Heat Generation.

Authors:  Shingo Kajimura; Bruce M Spiegelman; Patrick Seale
Journal:  Cell Metab       Date:  2015-10-06       Impact factor: 27.287

Review 8.  Prohibitin in Adipose and Immune Functions.

Authors:  Sudharsana R Ande; K Hoa Nguyen; B L Grégoire Nyomba; Suresh Mishra
Journal:  Trends Endocrinol Metab       Date:  2016-06-13       Impact factor: 12.015

9.  Age-associated telomere attrition in adipocyte progenitors predisposes to metabolic disease.

Authors:  Zhanguo Gao; Alexes C Daquinag; Cale Fussell; Zhongming Zhao; Yulin Dai; Angielyn Rivera; Brad E Snyder; Kristin L Eckel-Mahan; Mikhail G Kolonin
Journal:  Nat Metab       Date:  2020-12-14

10.  Peptide designed to elicit apoptosis in adipose tissue endothelium reduces food intake and body weight.

Authors:  Dong-Hoon Kim; Stephen C Woods; Randy J Seeley
Journal:  Diabetes       Date:  2010-01-26       Impact factor: 9.461

View more
  2 in total

Review 1.  Fatty acid translocase: a culprit of lipid metabolism dysfunction in disease.

Authors:  Joseph E Rupert; Mikhail G Kolonin
Journal:  Immunometabolism (Cobham)       Date:  2022-08-15

Review 2.  Maternal Supplementation of Probiotics, Prebiotics or Postbiotics to Prevent Offspring Metabolic Syndrome: The Gap between Preclinical Results and Clinical Translation.

Authors:  Ying-Hua Huang; You-Lin Tain; Chien-Ning Hsu
Journal:  Int J Mol Sci       Date:  2022-09-05       Impact factor: 6.208

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.